Ace Vision Group, Inc. (AVG) is an emerging ophthalmic laser device company that is pioneering a new rejuvenation therapy for the aging eye. Their innovative Eye Rejuvenation Laser Scleral Microporation (LSM) treatment aims to address presbyopia, a common age-related vision loss affecting billions of people worldwide.
Working closely with leading eye care professionals, AVG is at the forefront of the next revolution in eye care, with LSM currently in pilot clinical stages. Although the VisioLite Ophthalmic Laser System LSM is not yet FDA approved or available in the United States, it is undergoing clinical trials in select areas outside of the country.
Generated from the website